Avondale Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-43
Closed -$33.5K 126
2024
Q1
$33.5K Hold
43
0.02% 94
2023
Q4
$25.1K Hold
43
0.02% 99
2023
Q3
$23.1K Buy
+43
New +$22.2K 0.02% 102

Other funds holding LLY

Avondale Wealth Management's LLY Position: Q2 2024 in Review

Avondale Wealth Management sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 43 shares — an estimated $33.5K sold.

Avondale Wealth Management first reported a position in LLY in Q3 2023 and held it in 3 quarters. The position peaked at $33.5K in Q1 2024. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Avondale Wealth Management reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Avondale Wealth Management sold 43 Eli Lilly shares in Q2 2024, an estimated $33.5K.
  • Avondale Wealth Management first reported a position in Eli Lilly in Q3 2023 and held it in 3 quarters.
  • Avondale Wealth Management's Eli Lilly position peaked at $33.5K in Q1 2024.
  • 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Avondale Wealth Management's 13F filing for Q2 2024, filed 12 Jul 2024.